DESIGN AND EXECUTE A COHORT SCREENING PLAN FOR YOUR NEXT STUDY
Access Granted:
Using the world’s largest commercial repository of FFPE tissue coupled with expert histopathology, IHC, and genomic services.
Understand Testing Strategies
- Define the end goal: samples characterized for your biomarker of interest
- Utilize Discovery’s expertise to define appropriate testing methods
- Benefit from the experience of our expert scientists
- Leverage extensive IHC, PCR and genomic assay options
- Develop a strategy for a cohort of low prevalence markers
Access The World’s Largest Commercial FFPE Biorepository
- Access Discovery’s unrivaled FFPE biorepository to supply the maximum N for your study
- Perform high-throughput screening of your cohort
- Analyze results using our team of experts
Understand Testing Strategies
- Review the results and identify the samples of interest: known positives, negatives, and/or varying levels of expression
- Receive the full FFPE block from every case selected along with:
- Screening data
- Scoring/interpretation
- Aperio scans (if applicable)
- Complete de-identified original pathology reports
| EXAMPLE COHORTS | TEST AND MODALITY |
|---|---|
| MSI COLON, ENDO, GASTRIC | MMR (IHC), MSI (PCR) |
| HPV H&N, CERVICAL | p16 (IHC), HPV Subtyping (PCR) |
| LUNG ADENO COHORT | PD-L1, CD8 (IHC), Illumina TST170 (NGS) |
| NSCLC RARE FUSIONS | ALK, MET, RET, ROS1, NTRK (ISH, NGS) |
| DRIVER MUTATIONS | EGFR, KRAS, BRAF V600E (IHC, PCR, NGS) |
INTEGRATED WITH OUR EXPERT IHC SERVICES,
Discovery also has the world’s largest commercial biorepository of FFPE tissues and provides flow cytometry and sequencing services to fully understand target expression and comprehensively validate robust IHC assays.
IHC Services
FFPE Tissue
Flow Cytometry
To propel your projects with The Power of Discovery.™
Contact Us Today
Let us know about your project!
